Plain-language definitions grounded in the clinical and regulatory literature.
A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Disorder
What it isA sleep disorder where the normal paralysis during dreaming fails, causing people to physically act out their dreams—punching, kicking, yelling, or running while still asleep.
Why it mattersIt’s one of the strongest known predictors of future Parkinson’s disease, often appearing 10-15 years before other symptoms.
Think of it like thisNormally, your brain puts a ‘safety lock’ on your muscles while you dream, so you stay still even when you’re dreaming about running. RBD is like that lock failing—the motor is running (dreaming), and now you’re actually moving.
A parasomnia characterized by loss of normal REM sleep atonia (muscle paralysis), resulting in dream-enactment behaviors during REM sleep, and classified as a prodromal α-synucleinopathy.
MechanismREM atonia is generated by glutamatergic neurons in the sublaterodorsal tegmental nucleus (SLD) activating glycinergic/GABAergic interneurons in the ventromedial medulla and spinal cord. In idiopathic RBD, α-synuclein pathology damages these brainstem circuits before spreading rostrally.
Scientific ConsensusIsolated RBD converts to manifest synucleinopathy (PD, DLB, MSA) at >6% per year; cumulative conversion exceeds 80% over 10-15 years.
Active DebateEthical considerations of disclosing high conversion risk to patients and the utility of prodromal diagnosis without disease-modifying therapy.
Emerging ResearchBiomarkers for predicting phenoconversion timing and type; Neuroprotective trials in prodromal populations; GLP-1 agonists and α-synuclein aggregation inhibition; Whether RBD treatment modifies disease trajectory
Key ResearchSchenck et al. (1996) established the link to parkinsonism; Postuma et al. (2019) provided definitive natural history data.
— Multicenter study establishing iRBD as prodromal synucleinopathy with 80-90% phenoconversion risk
— Latest review of RBD as prodromal synucleinopathy with clinical and laboratory biomarker updates
— Neurologist guide to RBD including 70% synucleinopathy conversion within 12 years
— Motor dysfunction in iRBD as early marker of prodromal synucleinopathy
— Using RBD as window into prodromal Parkinson’s disease with implications for neuroprotection
Sleep disorders, PTSD, and the invisible wounds of service can feel isolating. If you or someone you know is in crisis or experiencing thoughts of self-harm, help is available right now. The Veterans Crisis Line provides free, confidential support 24 hours a day, 7 days a week to veterans, service members, and their families.
If you are in crisis or experiencing thoughts of self-harm, call the Veterans Crisis Line at